
|Videos|March 18, 2014
The Management of CLL in Elderly Patients
Author(s)Alessandra Ferrajoli, MD
Alessandra Ferrajoli, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the management of chronic lymphocytic leukemia (CLL) in elderly patients.
Advertisement
Alessandra Ferrajoli, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the management of chronic lymphocytic leukemia (CLL) in elderly patients.
Clinical Pearls:
- Clinical trials that have shown that the management of elderly patients with CLL needs to be different from the fit and young population
- Although there is no standard of care for elderly patients with CLL, physicians are starting to move away from chemoimmunotherapy and moving towards monoclonal antibody-based treatment
- In addition to considering the fitness and type of disease of elderly patients, physicians must consider transportation difficulties, limited financial budgets and ease of treatment
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5








































